Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Evelo Biosciences, Inc.

Evelo Biosciences Announces Top-Line Results From its Phase 2 Clinical Study with EDP2939 in Moderate Psoriasis
From Evelo Biosciences, Inc.
Via GlobeNewswire
Tickers EVLO
Evelo Biosciences Announces Second Quarter Financial Results and Recent Business Highlights
From Evelo Biosciences, Inc.
Via GlobeNewswire
Tickers EVLO
Evelo Biosciences Closes $25.5 Million Private Placement
From Evelo Biosciences, Inc.
Via GlobeNewswire
Tickers EVLO
Evelo Biosciences Announces $25.5 Million Private Placement
From Evelo Biosciences, Inc.
Via GlobeNewswire
Tickers EVLO
Evelo Biosciences Announces Reverse Stock Split Effective
From Evelo Biosciences, Inc.
Via GlobeNewswire
Tickers EVLO
Evelo Biosciences Provides Clinical Updates
From Evelo Biosciences, Inc.
Via GlobeNewswire
Tickers EVLO
Evelo Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
From Evelo Biosciences, Inc.
Via GlobeNewswire
Tickers EVLO
Evelo Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023
From Evelo Biosciences, Inc.
Via GlobeNewswire
Tickers EVLO
Evelo Biosciences to Participate in the Cowen 43rd Annual Health Care Conference
From Evelo Biosciences, Inc.
Via GlobeNewswire
Tickers EVLO
Evelo Biosciences Reports that EDP2939, its First Oral Extracellular Vesicle Product Candidate, Commenced Dosing in a Phase 2 Psoriasis Trial
From Evelo Biosciences, Inc.
Via GlobeNewswire
Tickers EVLO
Evelo Biosciences Provides Clinical and Business Updates
From Evelo Biosciences, Inc.
Via GlobeNewswire
Tickers EVLO
Evelo Biosciences Announces $45 Million Loan Agreement with Horizon Technology Finance Corporation to Refinance Existing Debt
From Evelo Biosciences, Inc.
Via GlobeNewswire
Tickers EVLO HRZN
Evelo Biosciences Announces Publication of Scientific Basis for SINTAX Medicines in Frontiers in Immunology
From Evelo Biosciences, Inc.
Via GlobeNewswire
Tickers EVLO
Evelo Biosciences Reports Third Quarter 2022 Financial Results and Business Highlights
From Evelo Biosciences, Inc.
Via GlobeNewswire
Tickers EVLO
Evelo Biosciences to Present at the 2022 Jefferies London Healthcare Conference
From Evelo Biosciences, Inc.
Via GlobeNewswire
Tickers EVLO
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.